Few depression treatments have arrived with as much noise as esketamine. It has been called a breakthrough and, less helpfully, a miracle. Neither word is a substitute for understanding what it is. Spravato is the brand name for esketamine, a prescription nasal spray approved by the FDA for treatment-resistant depression, and, separately, for depressive symptoms in adults with major depression who have acute suicidal thoughts or behavior. Here is the plain version.

How it is different from a pill

Most antidepressants act on serotonin, norepinephrine, or dopamine, and they take weeks to reach full effect. Esketamine works mainly on the brain's glutamate system, the most abundant excitatory signaling system in the brain. That different mechanism is the whole point: it offers a route to relief for people whose depression has not answered to serotonin-based drugs.

Because of how it works, some people notice a shift in mood faster than the weeks a traditional antidepressant needs. It is not instant, it is not universal, and it is not a cure. It is another tool, and for the right person it can be a meaningful one.

What an appointment actually looks like

This is the part that surprises people. Spravato is not a prescription you fill and take at home. Because of its effects, it is given only in a certified healthcare setting under the FDA's risk-management program, with monitoring built in.

  • You self-administer the nasal spray in the clinic, under the supervision of the care team.
  • You stay for monitoring, commonly around two hours, while a clinician checks blood pressure and how you are doing.
  • Because you may feel drowsy, dissociated, or lightheaded during that window, you cannot drive yourself home. You arrange a ride for the rest of the day.
  • Treatment usually follows a schedule, more frequent at first and then spaced out, alongside an oral antidepressant.
The dissociation questionDuring monitoring, some people feel a temporary sense of detachment, sometimes described as feeling apart from their body or surroundings. It typically fades within the monitoring window. Your care team expects this and watches for it, which is exactly why the treatment is delivered in a supervised clinic rather than at home.

The supervision is not a red flag. It is the design. Spravato trades the convenience of a home pill for a controlled setting and a mechanism that pills cannot reach.

The Gateway Health Review

Who it is generally for

Spravato is intended for adults whose depression has not responded adequately to other antidepressants, which is why an honest evaluation matters first. A clinic will review your history, the medications you have already tried, and your overall health to judge whether esketamine is a reasonable fit. People with certain cardiovascular or other medical conditions may not be candidates, and that screening is part of responsible care.

Spravato and ketamine are not the same thing

This confuses almost everyone. Ketamine has been used for decades as an anesthetic and is sometimes given off-label for depression as an infusion. Esketamine is a specific molecule derived from ketamine, formulated as a nasal spray, and carries a formal FDA approval for depression. If a clinic uses these terms interchangeably, ask them to be precise about what they offer and how it is regulated.

Getting a real evaluation near St. Louis

Esketamine is delivered at certified outpatient clinics, and several serve the St. Louis and St. Charles County area. Coverage, including through MO HealthNet, is worth confirming up front; our guide to paying for care covers that ground. If conventional medication has repeatedly fallen short, our piece on treatment-resistant depression explains where esketamine fits among the next options.